0 XP   0   0   0

Exicure Inc
Buy, Hold or Sell?

Should you buy, hold or sell Exicure Inc?

I guess you are interested in Exicure Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Exicure Inc

Let's start. I'm going to help you getting a better view of Exicure Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Exicure Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Exicure Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Exicure Inc. The closing price on 2023-01-27 was $1.4 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Exicure Inc Daily Candlestick Chart
Exicure Inc Daily Candlestick Chart
Summary









1. Valuation of Exicure Inc




Current price per share

$1.40

2. Growth of Exicure Inc




Is Exicure Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.7m$40.5m-$37.5m-1,259.6%

How much money is Exicure Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$15.7m$14.4m1,120.2%
Net Profit Margin-656.3%-6,933.6%--

How much money comes from the company's main activities?

3. Financial Health of Exicure Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#1131 / 1232

Most Revenue
#603 / 1232

Most Profit
#272 / 1232

Most Efficient
#904 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Exicure Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Exicure Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -256.0% means that $-2.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Exicure Inc:

  • The MRQ is -256.0%. The company is making a huge loss. -2
  • The TTM is -656.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-256.0%TTM-656.3%+400.3%
TTM-656.3%YOY-6,933.6%+6,277.3%
TTM-656.3%5Y-9,871.5%+9,215.2%
5Y-9,871.5%10Y-8,273.3%-1,598.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-256.0%-223.6%-32.4%
TTM-656.3%-281.7%-374.6%
YOY-6,933.6%-344.8%-6,588.8%
5Y-9,871.5%-450.1%-9,421.4%
10Y-8,273.3%-541.0%-7,732.3%
1.1.2. Return on Assets

Shows how efficient Exicure Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • -17.8% Return on Assets means that Exicure Inc generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Exicure Inc:

  • The MRQ is -17.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.8%TTM-4.5%-13.4%
TTM-4.5%YOY-19.0%+14.6%
TTM-4.5%5Y-13.5%+9.0%
5Y-13.5%10Y-3,277.5%+3,264.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.8%-9.9%-7.9%
TTM-4.5%-8.9%+4.4%
YOY-19.0%-9.3%-9.7%
5Y-13.5%-11.7%-1.8%
10Y-3,277.5%-12.7%-3,264.8%
1.1.3. Return on Equity

Shows how efficient Exicure Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Exicure Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Exicure Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.0%+0.0%
TTM0.0%YOY-63.2%+63.2%
TTM0.0%5Y-26.6%+26.6%
5Y-26.6%10Y-37.7%+11.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM0.0%-11.5%+11.5%
YOY-63.2%-10.8%-52.4%
5Y-26.6%-14.2%-12.4%
10Y-37.7%-15.2%-22.5%

1.2. Operating Efficiency of Exicure Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Exicure Inc is operating .

  • Measures how much profit Exicure Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • An Operating Margin of -255.8% means the company generated $-2.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Exicure Inc:

  • The MRQ is -255.8%. The company is operating very inefficient. -2
  • The TTM is -638.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-255.8%TTM-638.9%+383.2%
TTM-638.9%YOY-6,703.2%+6,064.2%
TTM-638.9%5Y-9,550.5%+8,911.6%
5Y-9,550.5%10Y-8,003.6%-1,546.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-255.8%-207.3%-48.5%
TTM-638.9%-271.0%-367.9%
YOY-6,703.2%-325.9%-6,377.3%
5Y-9,550.5%-454.0%-9,096.5%
10Y-8,003.6%-537.1%-7,466.5%
1.2.2. Operating Ratio

Measures how efficient Exicure Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.58 means that the operating costs are $3.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Exicure Inc:

  • The MRQ is 3.582. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.803. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.582TTM5.803-2.221
TTM5.803YOY68.596-62.794
TTM5.8035Y150.233-144.430
5Y150.23310Y125.930+24.303
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5822.871+0.711
TTM5.8033.504+2.299
YOY68.5963.604+64.992
5Y150.2335.132+145.101
10Y125.9306.371+119.559

1.3. Liquidity of Exicure Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Exicure Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.67 means the company has $0.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Exicure Inc:

  • The MRQ is 0.669. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.144. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.669TTM1.144-0.475
TTM1.144YOY4.940-3.796
TTM1.1445Y4.878-3.735
5Y4.87810Y4.252+0.626
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6695.117-4.448
TTM1.1445.755-4.611
YOY4.9405.854-0.914
5Y4.8786.511-1.633
10Y4.2526.222-1.970
1.3.2. Quick Ratio

Measures if Exicure Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.61 means the company can pay off $0.61 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Exicure Inc:

  • The MRQ is 0.609. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.105. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.609TTM1.105-0.497
TTM1.105YOY6.516-5.411
TTM1.1055Y5.792-4.686
5Y5.79210Y4.985+0.806
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6094.284-3.675
TTM1.1054.664-3.559
YOY6.5164.787+1.729
5Y5.7925.218+0.574
10Y4.9855.182-0.197

1.4. Solvency of Exicure Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Exicure Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Exicure Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.13 means that Exicure Inc assets are financed with 112.8% credit (debt) and the remaining percentage (100% - 112.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Exicure Inc:

  • The MRQ is 1.128. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.962. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.128TTM0.962+0.166
TTM0.962YOY0.537+0.425
TTM0.9625Y0.480+0.482
5Y0.48010Y0.776-0.296
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1280.278+0.850
TTM0.9620.277+0.685
YOY0.5370.306+0.231
5Y0.4800.367+0.113
10Y0.7760.403+0.373
1.4.2. Debt to Equity Ratio

Measures if Exicure Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Exicure Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Exicure Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.874-11.874
TTM11.874YOY1.749+10.126
TTM11.8745Y3.002+8.873
5Y3.00210Y2.859+0.142
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.315-0.315
TTM11.8740.317+11.557
YOY1.7490.319+1.430
5Y3.0020.403+2.599
10Y2.8590.462+2.397

2. Market Valuation of Exicure Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Exicure Inc generates.

  • Above 15 is considered overpriced but always compare Exicure Inc to the Biotechnology industry mean.
  • A PE ratio of -1.51 means the investor is paying $-1.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Exicure Inc:

  • The EOD is -1.347. Company is losing money. -2
  • The MRQ is -1.511. Company is losing money. -2
  • The TTM is -0.784. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.347MRQ-1.511+0.164
MRQ-1.511TTM-0.784-0.726
TTM-0.784YOY-0.584-0.201
TTM-0.7845Y-1.149+0.365
5Y-1.14910Y-0.958-0.192
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.347-8.986+7.639
MRQ-1.511-9.792+8.281
TTM-0.784-16.243+15.459
YOY-0.584-20.876+20.292
5Y-1.149-16.665+15.516
10Y-0.958-14.732+13.774
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Exicure Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Exicure Inc:

  • The MRQ is -1.154. Very Bad. -2
  • The TTM is -0.647. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.154TTM-0.647-0.507
TTM-0.647YOY-0.854+0.207
TTM-0.6475Y-0.305-0.343
5Y-0.30510Y-0.3050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.154-0.032-1.122
TTM-0.6470.004-0.651
YOY-0.8540.016-0.870
5Y-0.3050.006-0.311
10Y-0.3050.003-0.308

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Exicure Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -2.10 means the investor is paying $-2.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Exicure Inc:

  • The EOD is -1.877. Bad. Book ratio is negative. -2
  • The MRQ is -2.105. Bad. Book ratio is negative. -2
  • The TTM is 1.878. Good. +1
Trends
Current periodCompared to+/- 
EOD-1.877MRQ-2.105+0.228
MRQ-2.105TTM1.878-3.983
TTM1.878YOY0.247+1.631
TTM1.8785Y0.783+1.094
5Y0.78310Y0.653+0.131
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.8771.835-3.712
MRQ-2.1052.006-4.111
TTM1.8782.774-0.896
YOY0.2473.453-3.206
5Y0.7832.713-1.930
10Y0.6532.402-1.749
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Exicure Inc.

3.1. Institutions holding Exicure Inc

Institutions are holding 15.71% of the shares of Exicure Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-09-30Abingworth LLP5.67280.150128163600
2022-09-30Carlson Capital LP3.82710.02251900009000190.0019
2022-09-30Renaissance Technologies Corp1.60740.000279800-19095-19.3084
2022-09-30Northwestern University1.05030.080852145-1-0.0019
2022-09-30Vanguard Group Inc0.7014034822-55638-61.5056
2022-09-30Geode Capital Management, LLC0.447702222900
2022-09-30Sigma Planning Corp0.43920.001321807218070
2022-09-30BlackRock Inc0.2541012613-287-2.2248
2022-09-30HRT FINANCIAL LLC0.2450.000212164121640
2022-09-30Morgan Stanley - Brokerage Accounts0.059502953-1392-32.0368
2022-06-30Barclays PLC0.0019028662233352.7646
2022-09-30Bank of America Corp0.05430269826980
2022-09-30Tower Research Capital LLC0.04560.0001226332616.8301
2022-09-30Advisor Group Holdings, Inc.0.03740185518550
2022-09-30UBS Group AG0.0327016231290387.3874
2022-09-30Royal Bank of Canada0.0004022220
2022-09-30JPMorgan Chase & Co0.000201000
2022-06-30Goldman Sachs Group Inc000-4923-100
2022-06-30State Street Corporation000-6393-100
2022-06-30Cannell Peter B & CO Inc000-1333-100
Total 14.4770.2552721506+43334+6.0%

3.2. Funds holding Exicure Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-11-30Vanguard Extended Market Index Investor0.701403482200
2022-10-31Fidelity® Extended Market Index0.25540.00011268200
2022-11-30iShares Core S&P Total US Stock Mkt ETF0.143607128-21-0.2937
2022-03-31MIP Active Stock Master0.00360.0001536500
2022-06-30BlackRock Extended Mkt Composite0.00330.0001493449340
2022-10-31Fidelity® Total Market Index0.09020447900
2022-09-30BlackRock Extended Equity Market K0.08780.00014357-39-0.8872
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.04470.0001222100
2022-10-31Fidelity® Series Total Market Index0.04170207200
2022-10-31Fidelity® NASDAQ Composite Index®0.04110204100
2022-09-30Northern Trust Extended Eq Market Idx0.03950.0001196000
2022-09-30NT Ext Equity Mkt Idx Fd - L0.03950.0001196000
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.03610.00011791241.3582
2022-10-31Vifag 2002 SICAV0.03360.0055166600
2022-09-30SSgA U.S. Extended Market Index Class I0.01970.000197900
2022-11-30State St US Extended Mkt Indx NL Cl C0.0197097900
2022-10-31Spartan Total Market Index Pool E0.0112055700
2022-10-31Spartan Extended Market Index Pool E0.0080.000139800
2022-09-30NT US Market Cap Idx Fd - L0.0065032400
2022-09-30Northern Trust Wilshire 50000.0065032400
Total 1.63310.006591039+4898+5.4%

3.3. Insider Transactions

Insiders are holding 27.529% of the shares of Exicure Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-05-19Bali MuralidharBUY14721260.198449126
2021-12-21Gates Frontier, LlcSELL12686190.24
2021-08-27Elias D. PapadimasBUY100001.386537
2020-06-12Aurasense LlcSELL101952.8311257629
2019-08-02David R WaltBUY10000002
2019-03-21Chad A MirkinBUY10002.43
2019-03-19David A GiljohannBUY70002.4
2019-03-18Chad A MirkinBUY10002.4
2019-03-13Chad A MirkinBUY22002.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Exicure Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.980-0.891-9%-2.993+205%-0.155-84%-0.031-97%
Book Value Growth---3.184-0.433-86%0.691-561%0.942-438%26.178-112%
Book Value Per Share---0.7460.601-224%8.166-109%6.838-111%5.816-113%
Book Value Per Share Growth---3.184-0.433-86%0.691-561%0.942-438%26.178-112%
Current Ratio--0.6691.144-42%4.940-86%4.878-86%4.252-84%
Debt To Asset Ratio--1.1280.962+17%0.537+110%0.480+135%0.776+45%
Debt To Equity Ratio---11.874-100%1.749-100%3.002-100%2.859-100%
Dividend Per Share--0.0050.002+144%-+100%0.000+1120%0.000+1363%
Dividend Per Share Growth--1.5631.5630%--1.5630%1.5630%
Eps---1.039-1.753+69%-3.171+205%-1.627+57%-1.470+41%
Eps Growth--1.3091.306+0%0.696+88%0.694+89%0.694+89%
Free Cash Flow Per Share---1.319-1.685+28%-1.689+28%-1.233-7%-1.108-16%
Free Cash Flow Per Share Growth---721143.374-180285.805-75%1.259-57295187%-36056.237-95%-31353.206-96%
Free Cash Flow To Equity Per Share---1.319-2.065+56%-1.649+25%0.190-795%0.233-667%
Free Cash Flow To Equity Per Share Growth---1563243.823-390811.049-75%0.760-205806546%-78160.900-95%-67965.733-96%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1150.083--------
Intrinsic Value_10Y_min---39.788--------
Intrinsic Value_1Y_max--11.943--------
Intrinsic Value_1Y_min---6.311--------
Intrinsic Value_3Y_max--114.612--------
Intrinsic Value_3Y_min---17.062--------
Intrinsic Value_5Y_max--312.199--------
Intrinsic Value_5Y_min---25.647--------
Net Profit Margin---2.560-6.563+156%-69.336+2609%-98.715+3757%-82.733+3132%
Operating Margin---2.558-6.389+150%-67.032+2521%-95.505+3634%-80.036+3029%
Operating Ratio--3.5825.803-38%68.596-95%150.233-98%125.930-97%
Pb Ratio-1.877+11%-2.1051.878-212%0.247-952%0.783-369%0.653-422%
Pe Ratio-1.347+11%-1.511-0.784-48%-0.584-61%-1.149-24%-0.958-37%
Peg Ratio---1.154-0.647-44%-0.854-26%-0.305-74%-0.305-74%
Price Per Share1.400-12%1.5701.033+52%1.663-6%2.016-22%1.680-7%
Price To Total Gains Ratio-1.436+11%-1.610-1.828+14%-0.625-61%-1.346-16%-1.346-16%
Profit Growth---690761.052-172689.019-75%0.696-99183570%-34537.396-95%-30032.361-96%
Quick Ratio--0.6091.105-45%6.516-91%5.792-89%4.985-88%
Return On Assets---0.178-0.045-75%-0.190+7%-0.135-25%-32.775+18283%
Return On Equity---0.0000%-0.6320%-0.2660%-0.3770%
Revenue Growth--816194.332204049.498+300%-9.822+100%40810.859+1900%35487.945+2200%
Total Gains Per Share---0.975-0.889-9%-2.993+207%-0.155-84%-0.031-97%
Total Gains Per Share Growth---0.3530.590-160%0.687-151%1.175-130%1.113-132%
Usd Book Value---3703000.0002982000.000-224%40542500.000-109%33947200.000-111%28876405.667-113%
Usd Book Value Change Per Share---0.980-0.891-9%-2.993+205%-0.155-84%-0.031-97%
Usd Book Value Per Share---0.7460.601-224%8.166-109%6.838-111%5.816-113%
Usd Dividend Per Share--0.0050.002+144%-+100%0.000+1120%0.000+1363%
Usd Eps---1.039-1.753+69%-3.171+205%-1.627+57%-1.470+41%
Usd Free Cash Flow---6548000.000-8363002.270+28%-8387250.000+28%-6121300.454-7%-5502125.378-16%
Usd Free Cash Flow Per Share---1.319-1.685+28%-1.689+28%-1.233-7%-1.108-16%
Usd Free Cash Flow To Equity Per Share---1.319-2.065+56%-1.649+25%0.190-795%0.233-667%
Usd Price Per Share1.400-12%1.5701.033+52%1.663-6%2.016-22%1.680-7%
Usd Profit---5160000.000-1290019.980-75%-15740500.000+205%-6596153.996+28%-6063086.663+18%
Usd Revenue--2016000.000504002.180+300%-615250.000+131%976850.436+106%1160458.697+74%
Usd Total Gains Per Share---0.975-0.889-9%-2.993+207%-0.155-84%-0.031-97%
 EOD+2 -3MRQTTM+21 -19YOY+26 -145Y+16 -2410Y+17 -23

4.2. Fundamental Score

Let's check the fundamental score of Exicure Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.347
Price to Book Ratio (EOD)Between0-1-1.877
Net Profit Margin (MRQ)Greater than0-2.560
Operating Margin (MRQ)Greater than0-2.558
Quick Ratio (MRQ)Greater than10.609
Current Ratio (MRQ)Greater than10.669
Debt to Asset Ratio (MRQ)Less than11.128
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.178
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Exicure Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.380
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-09-302021-12-312022-03-312022-06-302022-09-30
Total Stockholder Equity 13,983-2,75111,232-7,9963,236-2,0731,163-4,866-3,703
Net Tangible Assets  13,983-2,75111,232-7,9963,236-2,0731,163-4,866-3,703
Net Working Capital  42,167-32,5689,599-1,7787,821-2,7565,065-13,577-8,512
Net Invested Capital  30,784-12,67918,105-14,8693,236-2,0731,163-4,866-3,703



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets28,942
Total Liabilities32,645
Total Stockholder Equity-3,703
 As reported
Total Liabilities 32,645
Total Stockholder Equity+ -3,703
Total Assets = 28,942

Assets

Total Assets28,942
Total Current Assets17,198
Long-term Assets17,198
Total Current Assets
Cash And Cash Equivalents 15,646
Other Current Assets 1,552
Total Current Assets  (as reported)17,198
Total Current Assets  (calculated)17,198
+/-0
Long-term Assets
Property Plant Equipment 10,467
Other Assets 1,277
Long-term Assets  (as reported)11,744
Long-term Assets  (calculated)11,744
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,710
Long-term Liabilities6,935
Total Stockholder Equity-3,703
Total Current Liabilities
Short-term Debt 517
Accounts payable 920
Other Current Liabilities 2,499
Total Current Liabilities  (as reported)25,710
Total Current Liabilities  (calculated)3,936
+/- 21,774
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,935
Long-term Liabilities  (as reported)6,935
Long-term Liabilities  (calculated)6,935
+/-0
Total Stockholder Equity
Retained Earnings -191,045
Accumulated Other Comprehensive Income -1
Other Stockholders Equity 187,343
Total Stockholder Equity (as reported)-3,703
Total Stockholder Equity (calculated)-3,703
+/-0
Other
Cash and Short Term Investments 15,646
Common Stock Shares Outstanding 4,963
Current Deferred Revenue21,774
Liabilities and Stockholders Equity 28,942
Net Debt -8,194
Net Invested Capital -3,703
Net Tangible Assets -3,703
Net Working Capital -8,512
Short Long Term Debt Total 7,452



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
> Total Assets 
0
20,576
7
7
25,371
28,055
24,354
19,343
35,526
28,756
25,184
20,256
73,806
115,263
105,529
96,119
111,280
100,444
87,948
74,467
77,900
64,868
41,896
36,955
28,942
28,94236,95541,89664,86877,90074,46787,948100,444111,28096,119105,529115,26373,80620,25625,18428,75635,52619,34324,35428,05525,3717720,5760
   > Total Current Assets 
0
20,041
7
7
24,280
26,706
23,047
18,073
34,364
27,663
23,616
18,760
71,753
112,776
101,744
89,389
96,829
86,322
73,987
60,647
64,147
43,666
29,182
24,721
17,198
17,19824,72129,18243,66664,14760,64773,98786,32296,82989,389101,744112,77671,75318,76023,61627,66334,36418,07323,04726,70624,2807720,0410
       Cash And Cash Equivalents 
0
19,623
7
7
22,936
25,764
21,124
16,380
32,446
26,268
22,196
17,175
70,392
48,460
24,577
17,198
31,459
33,262
34,296
42,587
51,885
34,644
23,890
21,198
15,646
15,64621,19823,89034,64451,88542,58734,29633,26231,45917,19824,57748,46070,39217,17522,19626,26832,44616,38021,12425,76422,9367719,6230
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
62,326
74,223
68,579
62,621
48,818
33,140
13,472
8,953
4,497
2,494
997
0
09972,4944,4978,95313,47233,14048,81862,62168,57974,22362,3260000000000000
       Net Receivables 
0
15
0
0
214
30
26
70
63
13
6
11
16
271
436
245
448
11
224
44
27
0
0
0
0
000027442241144824543627116116136370263021400150
       Other Current Assets 
0
403
0
0
1,130
912
1,897
1,623
1,855
1,382
1,414
1,574
1,345
1,719
2,508
3,367
2,301
4,231
6,327
4,544
3,309
4,525
2,798
2,526
1,552
1,5522,5262,7984,5253,3094,5446,3274,2312,3013,3672,5081,7191,3451,5741,4141,3821,8551,6231,8979121,130004030
   > Long-term Assets 
0
535
0
0
1,091
1,349
1,307
1,270
1,162
1,093
1,568
1,496
2,053
2,487
3,785
6,730
14,451
14,122
13,961
13,820
13,753
21,202
12,714
12,234
11,744
11,74412,23412,71421,20213,75313,82013,96114,12214,4516,7303,7852,4872,0531,4961,5681,0931,1621,2701,3071,3491,091005350
       Property Plant Equipment 
0
503
0
0
1,059
1,317
1,275
1,206
1,130
1,061
1,529
1,452
2,021
2,455
3,498
4,464
13,037
12,729
12,535
12,383
12,288
11,877
11,393
10,934
10,467
10,46710,93411,39311,87712,28812,38312,53512,72913,0374,4643,4982,4552,0211,4521,5291,0611,1301,2061,2751,3171,059005030
       Other Assets 
0
0
0
0
32
32
32
64
32
32
39
44
32
32
1,202
2,266
1,414
9,999
1,426
1,437
1,465
9,325
1,321
1,300
1,277
1,2771,3001,3219,3251,4651,4371,4269,9991,4142,2661,202323244393232643232320000
> Total Liabilities 
0
18,128
27
27
13,689
9,108
8,046
9,441
10,328
7,804
9,029
8,865
8,854
34,516
20,415
14,367
37,852
38,938
37,907
37,827
63,917
53,636
38,660
35,792
32,645
32,64535,79238,66053,63663,91737,82737,90738,93837,85214,36720,41534,5168,8548,8659,0297,80410,3289,4418,0469,10813,689272718,1280
   > Total Current Liabilities 
0
12,158
27
27
10,529
3,452
3,015
4,267
9,302
2,043
8,221
8,098
8,273
31,087
20,373
14,367
12,609
13,734
12,763
12,745
21,980
34,067
21,361
19,656
25,710
25,71019,65621,36134,06721,98012,74512,76313,73412,60914,36720,37331,0878,2738,0988,2212,0439,3024,2673,0153,45210,529272712,1580
       Short-term Debt 
0
1,213
25
25
2,551
4,855
776
1,570
4,926
0
4,986
5,125
5,191
5,257
275
196
177
223
327
420
0
13,746
0
0
517
5170013,74604203272231771962755,2575,1915,1254,98604,9261,5707764,8552,55125251,2130
       Short Long Term Debt 
0
0
5,667
0
2,551
4,855
776
1,570
4,926
0
4,807
4,859
4,912
4,965
0
0
0
0
0
0
0
6,873
0
0
0
0006,87300000004,9654,9124,8594,80704,9261,5707764,8552,55105,66700
       Accounts payable 
0
509
0
0
2,379
1,049
974
1,045
1,341
500
848
917
1,110
1,814
3,392
1,540
2,006
1,866
2,976
2,250
2,485
3,413
1,918
1,593
920
9201,5931,9183,4132,4852,2502,9761,8662,0061,5403,3921,8141,1109178485001,3411,0459741,0492,379005090
       Other Current Liabilities 
0
2,160
0
0
2,496
1,369
1,265
1,652
3,035
1,543
1,412
1,515
1,958
2,143
993
1,751
1,947
3,302
2,114
2,808
5,480
-409
3,227
3,308
2,499
2,4993,3083,227-4095,4802,8082,1143,3021,9471,7519932,1431,9581,5151,4121,5433,0351,6521,2651,3692,496002,1600
   > Long-term Liabilities 
0
5,970
0
25
3,160
5,656
5,031
5,174
1,026
5,761
808
767
581
3,429
42
0
25,243
25,204
25,144
25,082
41,937
19,569
17,299
16,136
6,935
6,93516,13617,29919,56941,93725,08225,14425,20425,2430423,4295817678085,7611,0265,1745,0315,6563,1602505,9700
       Long term Debt Total 
0
0
0
0
0
0
4,103
3,333
0
4,925
0
0
0
0
0
0
0
16,589
0
0
0
0
0
0
0
000000016,58900000004,92503,3334,103000000
       Other Liabilities 
0
0
0
0
490
801
928
1,841
1,026
836
428
541
437
3,370
42
0
656
656
656
656
17,585
12,165
10,045
9,035
0
09,03510,04512,16517,5856566566566560423,3704375414288361,0261,8419288014900000
> Total Stockholder Equity
0
2,448
-40,182
0
11,682
18,947
16,308
9,902
25,198
20,952
16,155
11,391
64,952
80,747
85,114
81,752
73,428
61,506
50,041
36,640
13,983
11,232
3,236
1,163
-3,703
-3,7031,1633,23611,23213,98336,64050,04161,50673,42881,75285,11480,74764,95211,39116,15520,95225,1989,90216,30818,94711,6820-40,1822,4480
   Common Stock
0
0
0
0
4
4
4
4
4
4
4
4
8
9
9
9
9
9
9
9
9
11
12
0
0
001211999999998444444440000
   Retained Earnings Total Equity00000-132,711-118,442-105,96500000000000000000
   Accumulated Other Comprehensive Income 
0
-617
0
0
-776
-849
-918
-1,007
-1,097
-1,189
-1,276
-1,363
-1,454
-27
-17
338
200
83
32
5
-1
-2
-5
-5
-1
-1-5-5-2-153283200338-17-27-1,454-1,363-1,276-1,189-1,097-1,007-918-849-77600-6170
   Capital Surplus 
0
0
0
0
0
0
54,394
54,813
75,433
75,942
76,431
76,887
136,260
162,062
165,269
0
0
167,379
168,442
169,337
0
0
0
0
0
00000169,337168,442167,37900165,269162,062136,26076,88776,43175,94275,43354,81354,394000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
25,669
0
0
43,219
53,586
55,312
55,820
76,530
77,131
77,707
78,250
137,714
162,062
165,269
165,863
166,499
167,379
168,442
169,337
170,217
181,290
181,644
187,053
187,343
187,343187,053181,644181,290170,217169,337168,442167,379166,499165,863165,269162,062137,71478,25077,70777,13176,53055,82055,31253,58643,2190025,6690



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue-483
Cost of Revenue--
Gross Profit--483
 
Operating Income (+$)
Gross Profit-
Operating Expense-62,066
Operating Income-62,549-62,066
 
Operating Expense (+$)
Research Development48,979
Selling General Administrative13,087
Selling And Marketing Expenses-
Operating Expense62,06662,066
 
Net Interest Income (+$)
Interest Income141
Interest Expense-1,691
Net Interest Income-1,550-1,550
 
Pretax Income (+$)
Operating Income-62,549
Net Interest Income-1,550
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-64,102-60,996
EBIT - interestExpense = -1,691
-64,102
-62,411
Interest Expense1,691
Earnings Before Interest and Taxes (ebit)0-62,411
Earnings Before Interest and Taxes (ebitda)1,123
 
After tax Income (+$)
Income Before Tax-64,102
Tax Provision-0
Net Income From Continuing Ops-64,102-64,102
Net Income-64,102
Net Income Applicable To Common Shares-64,102
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,5531,550
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CMBN.SW
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CMBN.SW.

CMBN.SW Daily Candlestick Chart
6MK.STU
5 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6MK.STU.

6MK.STU Daily Candlestick Chart
GGRO.TO
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GGRO.TO.

GGRO.TO Daily Candlestick Chart
0RYA.IL
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0RYA.IL.

0RYA.IL Daily Candlestick Chart
USCU.V
7 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of USCU.V.

USCU.V Daily Candlestick Chart
CNE.TO
8 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNE.TO.

CNE.TO Daily Candlestick Chart
BARU.V
9 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of BARU.V.

BARU.V Daily Candlestick Chart
ALVO.IC
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALVO.IC.

ALVO.IC Daily Candlestick Chart
HURA.TO
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HURA.TO.

HURA.TO Daily Candlestick Chart
IGF.NASDAQ
18 minutes ago

I found you a Golden Cross on the daily chart of IGF.NASDAQ.

IGF.NASDAQ Daily Candlestick Chart
IGBH.NYSE ARC
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGBH.NYSE ARC.

IGBH.NYSE ARC Daily Candlestick Chart
IFGL.NASDAQ
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IFGL.NASDAQ.

IFGL.NASDAQ Daily Candlestick Chart
IEMG.NYSE ARC
18 minutes ago

I found you a Golden Cross on the daily chart of IEMG.NYSE ARC.

IEMG.NYSE ARC Daily Candlestick Chart
IDRV.NYSE ARC
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDRV.NYSE ARC.

IDRV.NYSE ARC Daily Candlestick Chart
KESAR.BSE
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KESAR.BSE.

KESAR.BSE Daily Candlestick Chart
SGAMY.PINK
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGAMY.PINK.

SGAMY.PINK Daily Candlestick Chart
RUG.V
22 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUG.V.

RUG.V Daily Candlestick Chart
FLRK.LSE
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRK.LSE.

FLRK.LSE Daily Candlestick Chart
3BAB.LSE
23 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BAB.LSE.

3BAB.LSE Daily Candlestick Chart
IWSY.OTCQB
23 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of IWSY.OTCQB.

IWSY.OTCQB Daily Candlestick Chart
HITC.PINK
23 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HITC.PINK.

HITC.PINK Daily Candlestick Chart
ENRT.OTCQB
25 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENRT.OTCQB.

ENRT.OTCQB Daily Candlestick Chart
SCOB.NASDAQ
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCOB.NASDAQ.

SCOB.NASDAQ Daily Candlestick Chart
MDMN.PINK
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDMN.PINK.

MDMN.PINK Daily Candlestick Chart
TRRE.PINK
26 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of TRRE.PINK.

TRRE.PINK Daily Candlestick Chart